Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.
about
Hepatitis C virus and neurological damageDepression and suicide ideation in chronic hepatitis C patients untreated and treated with interferon: prevalence, prevention, and treatmentBarriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a reviewDrug-Drug Interactions Between Direct-Acting Antivirals and Psychoactive MedicationsQuinolinic Acid Responses during Interferon-α-Induced Depressive Symptomatology in Patients with Chronic Hepatitis C Infection - A Novel Aspect for Depression and Inflammatory HypothesisDepression and Chronic Liver Diseases: Are There Shared Underlying Mechanisms?Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical TrialPsychiatric treatment considerations with direct acting antivirals in hepatitis CEvaluation of cellular responses for a chimeric HBsAg-HCV core DNA vaccine in BALB/c miceWhat psychiatric screening and monitoring might be needed with the new generation of hepatitis C treatments?Identification of novel human kinases that suppress hepatitis C virus infection.Persistent neurocognitive decline in a clinic sample of hepatitis C virus-infected persons receiving interferon and ribavirin treatmentA longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C.Psychiatric Adverse Effects Of Interferon Therapy.Personality disorders do not affect treatment outcomes for chronic HCV infection in Spanish prisoners: the Perseo studyFacilitators of HCV treatment adherence among people who inject drugs: a systematic qualitative review and implications for scale up of direct acting antivirals.Treatment-emergent depression and anxiety between peginterferon alpha-2a versus alpha-2b plus ribavirin for chronic hepatitis C.Hepatitis C virus infection, and neurological and psychiatric disorders - A review.Nutrition, psychoneuroimmunology and depression: the therapeutic implications of omega-3 fatty acids in interferon-α-induced depression.A Birth-cohort testing intervention identified hepatitis c virus infection among patients with few identified risks: a cross-sectional study.Probable involvement of p11 with interferon alpha induced depressionNeuropsychiatric and psychosocial issues of patients with hepatitis C infection: a selective literature reviewMental health problems in people living with HIV: changes in the last two decades: the London experience 1990-2014.Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression.Interferon-Related Depression: A Primer on Mechanisms, Treatment, and Prevention of a Common Clinical Problem.Impact of HCV treatment and depressive symptoms on adherence to HAART among HIV-HCV-coinfected patients: results from the ANRS-CO13-HEPAVIH cohort.The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV).The new paradigm of hepatitis C therapy: integration of oral therapies into best practices.Liver Illness and Psychiatric Patients.Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment.Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.Serotonin and its implication in the side-effects of interferon-based treatment of patients with chronic viral hepatitis: Pharmacological interventions.Treatment decisions and contemporary versus pending treatments for hepatitis C.Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review.Review article: depression and the use of antidepressants in patients with chronic liver disease or liver transplantation.Hepatitis C virus infection treatment: An era of game changer direct acting antivirals and novel treatment strategies.Impact of hepatitis C virus infection on health-related quality of life before and after liver transplantation: a multidisciplinary point of view.Cognitive impairment in relation to depression, anxiety and virological response in hepatitis C patients in Egypt.Sexual dysfunction and dissatisfaction in chronic hepatitis C patients.Depression in HIV and HCV co-infected patients: a systematic review and meta-analysis.
P2860
Q26748575-CEBB11ED-0207-4200-A5A3-2A1BC35F6D7AQ26783698-C4BA4744-12F3-4B92-AAF5-651D613A9FA6Q27010548-EA87AACA-2505-4531-8BBB-E88F25510524Q28069639-4E8F4B28-6B9C-4EBA-817B-2C141AFB66A9Q28607691-FAE44A51-F282-444D-A3B7-1EE399812B7FQ33645706-5B58C4A8-EEAB-49E6-BDC0-117D754133A0Q33647262-19662B1B-F5CC-49C9-BCCF-D44E42DF18E0Q34721628-21E495A7-D899-4570-AC34-342B3B15F15CQ34990860-5CCD9C0A-3381-4111-84AC-EE807EA5B4DEQ35019908-3763DCD6-7659-4121-80E1-62880C19BB17Q35037141-2DA1D967-1C8D-4603-864A-42498DD090CDQ35201308-07D15367-2D31-4885-922A-280EB3250649Q35619107-A71E5C6C-6030-44C8-A1B2-CFEA83C6A298Q35713956-3F78D259-A8E0-4DAE-9A83-1822606489E9Q35749560-FBFB9E79-55C1-431D-8C87-813B4A3E9085Q36137527-977155A7-6A1B-45F7-85CF-6DCE9284904BQ36203547-52A14FE3-1BD6-4EED-B10D-AD3BE1DE16DAQ36266948-6E32F664-C932-4F30-80A4-C6664F145103Q36327782-B4D37294-37A9-42FF-983B-670F0FD16651Q36340733-63F50721-9A5D-42D7-A32B-B103DEB03E95Q36517077-39351981-307B-4D44-9541-4058F141F2EFQ36638638-2161BBD9-7C6B-4511-8FDD-DB6E24D4AB29Q36789636-BAF88E38-DB3B-47B2-AF8E-869A8A754E9FQ36852421-CC4E5EA6-9966-47C2-BD6B-FA500559DC23Q37310556-7FEE7F08-7707-4161-8B1B-DC52BE204320Q37410198-C77E69B1-97DC-441B-9F39-6F4AA97BD766Q37432877-7A1B6B38-F034-41F7-9674-F4414CF31318Q37455611-DA39D735-AB38-4CE3-A182-A8A0148C8316Q37587062-D2DB7CE5-EDD8-4A28-A8D5-136DB93F10AFQ37652906-7126B1B4-F156-45A0-B9A9-72FB417FB74CQ38064495-EDB14492-5174-4FD9-AE5E-2067E053F5D4Q38100813-EB629EF7-F75F-4A46-8AB4-472327E1F38BQ38135774-383DE85C-1849-4C06-A7A3-68CA504FACC6Q38163604-184399E5-E0D4-43B8-A596-614A17739D94Q38245124-D719A5C5-739A-46DF-8664-E1402E43E59BQ38265395-25026BC2-37F6-4373-A413-8F399BA5102CQ38653173-52A6E248-DAE3-4037-B6BC-0A7F377215E1Q38895939-180BD786-DBC0-4967-86AD-9275869E8803Q39014560-B9FE9E2D-05CB-45EC-B53A-7DBE2EB21506Q39093985-1A4CEC81-F93A-4EF2-9F17-05FC0CB7F311
P2860
Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Hepatitis C infection, antivir ...... an expert consensus statement.
@ast
Hepatitis C infection, antivir ...... an expert consensus statement.
@en
Hepatitis C infection, antivir ...... an expert consensus statement.
@nl
type
label
Hepatitis C infection, antivir ...... an expert consensus statement.
@ast
Hepatitis C infection, antivir ...... an expert consensus statement.
@en
Hepatitis C infection, antivir ...... an expert consensus statement.
@nl
prefLabel
Hepatitis C infection, antivir ...... an expert consensus statement.
@ast
Hepatitis C infection, antivir ...... an expert consensus statement.
@en
Hepatitis C infection, antivir ...... an expert consensus statement.
@nl
P2093
P50
P1476
Hepatitis C infection, antivir ...... an expert consensus statement.
@en
P2093
Achim Kautz
Astrid Friebe
Daniel Forton
Geert Robaeys
Graham R Foster
Martin Schaefer
P304
P356
10.1016/J.JHEP.2012.07.037
P577
2012-08-07T00:00:00Z